[HTML] plos.org

[HTML][HTML] Efficacy and safety of gemcitabine-fluorouracil combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomized …

Q Li, H Yan, W Liu, H Zhen, Y Yang, B Cao - PLoS One, 2014 - journals.plos.org
Background Gemcitabine (GEM) is the standard first-line chemotherapy that provides limited
clinical benefits for patients with locally advanced/metastatic pancreatic adenocarcinoma …
被引用次数：51 相关文章

Efficacy and Safety of Gemcitabine-Fluorouracil Combination Therapy in the Management of Advanced Pancreatic Cancer: A Meta-Analysis of Randomized …

Q Li, H Yan, W Liu, H Zhen, Y Yang, B Cao - PLOS ONE, 2014 - ideas.repec.org
Background: Gemcitabine (GEM) is the standard first-line chemotherapy that provides
limited clinical benefits for patients with locally advanced/metastatic pancreatic …
[PDF] scienceopen.com

[PDF][PDF] Efficacy and Safety of Gemcitabine-Fluorouracil Combination Therapy in the Management of Advanced

Q Li, H Yan, W Liu, H Zhen, Y Yang - 2014 - scienceopen.com
Background: Gemcitabine (GEM) is the standard first-line chemotherapy that provides
limited clinical benefits for patients with locally advanced/metastatic pancreatic …

[引用][C] Efficacy and Safety of Gemcitabine-Fluorouracil Combination Therapy in the Management of Advanced Pancreatic Cancer: A Meta-Analysis of Randomized …

Q Li, H Yan, W Liu, H Zhen, Y Yang, B Cao - PLoS ONE, 2014 - ui.adsabs.harvard.edu
Efficacy and Safety of Gemcitabine-Fluorouracil Combination Therapy in the Management of
Advanced Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials - NASA/ADS …

Efficacy and Safety of Gemcitabine-Fluorouracil Combination Therapy in the Management of Advanced Pancreatic Cancer: A Meta-Analysis of Randomized …

Q Li, H Yan, W Liu, H Zhen, Y Yang, B Cao - PLOS ONE, 2014 - econpapers.repec.org
Background: Gemcitabine (GEM) is the standard first-line chemotherapy that provides
limited clinical benefits for patients with locally advanced/metastatic pancreatic …
[PDF] psu.edu

[PDF][PDF] Efficacy and Safety of Gemcitabine-Fluorouracil Combination Therapy in the Management of Advanced

Q Li, H Yan, W Liu, H Zhen, Y Yang - 2014 - Citeseer
Background: Gemcitabine (GEM) is the standard first-line chemotherapy that provides
limited clinical benefits for patients with locally advanced/metastatic pancreatic …

Efficacy and safety of gemcitabine-fluorouracil combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomized controlled trials …

Q Li, H Yan, W Liu, H Zhen, Y Yang, B Cao - Plos one, 2014 - europepmc.org
Background Gemcitabine (GEM) is the standard first-line chemotherapy that provides limited
clinical benefits for patients with locally advanced/metastatic pancreatic adenocarcinoma …
[HTML] nih.gov

[HTML][HTML] Efficacy and Safety of Gemcitabine-Fluorouracil Combination Therapy in the Management of Advanced Pancreatic Cancer: A Meta-Analysis of Randomized …

Q Li, H Yan, W Liu, H Zhen, Y Yang, B Cao - PLoS ONE, 2014 - ncbi.nlm.nih.gov
Background Gemcitabine (GEM) is the standard first-line chemotherapy that provides limited
clinical benefits for patients with locally advanced/metastatic pancreatic adenocarcinoma …
[PDF] semanticscholar.org

[PDF][PDF] Efficacy and Safety of Gemcitabine-Fluorouracil Combination Therapy in the Management of Advanced

Q Li, H Yan, W Liu, H Zhen, Y Yang - 2014 - pdfs.semanticscholar.org
Background: Gemcitabine (GEM) is the standard first-line chemotherapy that provides
limited clinical benefits for patients with locally advanced/metastatic pancreatic …

Efficacy and Safety of Gemcitabine-Fluorouracil Combination Therapy in the Management of Advanced Pancreatic Cancer: A Meta-Analysis of Randomized …

Q Li, H Yan, W Liu, H Zhen, Y Yang, B Cao - PLoS ONE, 2014 - search.ebscohost.com
Background: Gemcitabine (GEM) is the standard first-line chemotherapy that provides
limited clinical benefits for patients with locally advanced/metastatic pancreatic …